Cargando…
Abstract 16 New Advanced Therapy Medicinal Products (ATMPs) in Medical Trials: A FamiCord Group Development Pipeline Update
INTRODUCTION: Seventeen products in five countries are used in medical experiments and clinical trials. FamiCord Group, the leading stem cell bank in Europe and number 3 worldwide, is a listed biotech group consisting of the European biotech companies Vita 34 (Germany), P.B.K.M. (Poland), Crioestami...
Autores principales: | Gerth, André, Heike Opitz, Constanze, Baran, Tomasz, Oldak, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446905/ http://dx.doi.org/10.1093/stcltm/szac057.016 |
Ejemplares similares
-
Abstract 18 Developing a Potency Assay for Cord Tissue MSCs
por: Parrott, Roberta, et al.
Publicado: (2022) -
Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
por: Rico, Jessica Patiño, et al.
Publicado: (2023) -
Abstract 17 Comparison of Different Support Materials and Cryoprotectants for Amniotic Membrane Cryopreservation
por: Ogliari, Karolyn, et al.
Publicado: (2022) -
Eye banking: an introduction
por: Rao, Gullapalli N, et al.
Publicado: (2009) -
Optic neuropathy in a COVID-19 patient
por: Borrego-Sanz, L., et al.
Publicado: (2021)